# Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline

> **NCT05514171** · — · COMPLETED · sponsor: **Hospital del Mar** · enrollment: 300 (actual)

## Conditions studied

- Chemotherapy Effect
- Pancreas Cancer

## Interventions

- **PROCEDURE:** Neoadyuvant therapy

## Key facts

- **NCT ID:** NCT05514171
- **Lead sponsor:** Hospital del Mar
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05514171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05514171, "Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05514171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*